Table 1 Baseline characteristics of subjects
Study | 1. High dose salbutamol | 2. Ipratropium |
|---|---|---|
Number of subjects | 11 | 11 |
Male | 3 | 3 |
Age (range) | 37 (22 to 62) | 34 (19 to 53) |
Number on inhaled steroids Dose range (μg)(budesonide equivalent) | 9 (200 to 1200) | 10 (200 to 2000) |
FEV1% predicted at screening (range) | 79 (61 to 101) | 86 (65 to 103) |